A previous study showed that hepatic SENP3 expression level was increased after loading hepatocytes with free fatty acids (FFAs) in vitro and in an animal model and NAFLD patients in vivo. The gene discussed is SENP3; the disease is metabolic dysfunction-associated steatotic liver disease.